Levodopa with carbidopa and entacapone – July 2024

Levodopa with Carbidopa and Entacapone; Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg and with entacapone 20 mg per mL, 47 mL; Lecigon® – July 2024 – November 2024

Brand names:
- Lecigon®
Pharmaceutical Company:
- STADA PHARMACEUTICALS AUSTRALIA PTY LIMITED
Condition/Indication: Advanced Parkinson disease
Meeting Date: July 2024
Public Summary Document (PSD) July 2024 November 2024 PBAC Meetings - (PDF 2MB)
Public Summary Document (PSD) July 2024 November 2024 PBAC Meetings - (Word 1.4MB)

Related Public Summary Documents

Levodopa with carbidopa and entacapone – November 2024

Last updated

30 May 2025